April 10, 2015
Kowa announced on April 8 that its hyperlipidemia treatment pitavastatin (brand name in Japan: Livalo) had no negative effects on fasting blood glucose levels and HbA1c in comparison with placebo and other statins. The data are from the meta-analysis of...read more